Trial status
This protocol is currently on version 8, July 28, 2021. Trial enrollment began on September 8, 2020. The anticipated end of enrollment is December 31, 2023. Long-term follow-up will be completed on February 28, 2026. The trial was registered on January 2, 2020; NCT04214834.
